This inventor holds 3 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Quest Diagnostics Investments, Inc., Athena Diagnostics, Inc.. Active years: 2020-2024.
Location History:
- Newton, MA (US) (2020)
- San Juan Capistrano, CA (US) (2020)
Company Filing History:
2 out of 499 
1 out of 23 
Years Active: 2020-2024
Title: Christopher D Elzinga: Innovator in Genetic Analysis
Introduction
Christopher D Elzinga is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of genetic analysis, holding a total of 3 patents. His work focuses on developing methods and systems that enhance the understanding of genetic variations and their implications in clinical settings.
Latest Patents
One of his latest patents is titled "Detecting Genetic Copy Number Variation." This invention includes systems, apparatus, and methods for detecting copy number variation (CNV) in the genomes of one or more patients. The process involves taking DNA samples from several patients, sequencing sections of their DNA, and analyzing the data to identify CNV. The methodology includes various steps such as purifying, concentrating, fragmenting, labeling, filtering, and amplifying the DNA. The sequencing data undergoes normalization and analysis to report the CNV findings.
Another significant patent is the "Pathogenicity Scoring System for Human Clinical Genetics." This invention provides methods and systems for determining the clinical significance of a genetic variant. The process involves calculating several scores, including a function score, frequency score, co-occurrence score, and family segregation score. These scores are aggregated to generate a clinical significance score that indicates the relevance of the genetic variant in clinical contexts.
Career Highlights
Christopher has worked with prominent companies in the field, including Quest Diagnostics Investments, Inc. and Athena Diagnostics, Inc. His experience in these organizations has contributed to his expertise in genetic analysis and innovation.
Collaborations
Throughout his career, Christopher has collaborated with talented individuals such as Matthew Evans and Corey Brastaad. These partnerships have likely enriched his work and led to advancements in genetic research.
Conclusion
Christopher D Elzinga is a distinguished inventor whose work in genetic analysis has led to valuable patents that enhance our understanding of genetic variations. His contributions are significant in the field of clinical genetics, and his innovations continue to impact the industry positively.